Download presentation
Presentation is loading. Please wait.
Published byMargaretMargaret Beasley Modified over 6 years ago
1
Emergency care of patients receiving non-vitamin K antagonist oral anticoagulants
J.W. Eikelboom, S. Kozek-Langenecker, A. Exadaktylos, A. Batorova, Z. Boda, F. Christory, I. Gornik, G. Kėkštas, A. Kher, R. Komadina, O. Koval, G. Mitic, T. Novikova, E. Pazvanska, S. Ratobilska, J. Sütt, A. Winder, D. Zateyshchikov British Journal of Anaesthesia Volume 120, Issue 4, Pages (April 2018) DOI: /j.bja Copyright © 2017 The Author(s) Terms and Conditions
2
Fig 1 Management of bleeding in patients treated with non-vitamin K antagonist oral anticoagulants (NOACs). aPCC, activated prothrombin complex concentrate; PCC, prothrombin complex concentrate; recombinant activated factor, rFVIIa. British Journal of Anaesthesia , DOI: ( /j.bja ) Copyright © 2017 The Author(s) Terms and Conditions
3
Fig 2 Management of non-vitamin K antagonist oral anticoagulant (NOAC)-treated patients who require an emergency surgical or invasive procedure. aPCC, activated prothrombin complex concentrate; PCC, prothrombin complex concentrate; recombinant activated factor, rFVIIa. British Journal of Anaesthesia , DOI: ( /j.bja ) Copyright © 2017 The Author(s) Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.